ENDS US provides attendees with actionable considerations to help navigate the varied approaches and new developments that are influencing the electronic nicotine delivery systems industry, impending regulations, and the future of the electronic nicotine delivery systems marketplace in the United States and around the globe.
This leading industry event attracts a wide variety of key players from across the regulatory, testing, and commercial sectors for an independent and objective forum regarding the scientific research, compliance standards, and regulations of electronic nicotine delivery systems (ENDS).
Content in (EST) Eastern Standard Time
Danielle began working in the vaping industry in 2013 as a Graphic Designer and about a year later she was finally able to quit a 10 year smoking habit. In 2015 she created a popular series of videos on YouTube called “The Truth About Vaping” which launched her journey into Tobacco Harm Reduction advocacy. She served on the board of Not Blowing Smoke from 2016-2017 and joined the board of the Consumer Advocates for Smoke-free Alternatives Association (CASAA) in 2019. In 2021 she was elected President of the Board of CASAA. Danielle is passionate about harm reduction, advocacy, and making sure the consumer voice is represented in policy debates and decisions. She frequently creates educational graphics for circulation on social media, in addition to researching and writing on the politics and misinformation surrounding vaping.
Dov is a seasoned tax and regulatory attorney with over 20 years of experience in state and local tax and regulatory matters with a focus on tobacco, vapor, CBD and cannabis products.
He has advised clients in the areas of federal and state, cigarette, tobacco, cannabis and vapor excise tax, licensing and regulatory matters. Dov regularly advises clients on all aspects of compliance with the Prevent All Cigarette Trafficking Act (“PACT Act”).
Dov acts as primary excise tax and regulatory counsel for a broad range of companies. He represents clients before various regulatory agencies including: the Food and Drug Administration (FDA), Alcohol and Tobacco Tax and Trade Bureau (TTB) and state taxing authorities.
Christopher Russell, Ph.D. is a behavioral psychologist and Director of Russell Burnett Research & Consultancy Ltd (RBRC), a contract research organization that specializes in the design, conduct, and reporting of perception and behavioral studies of the potential population health risks and benefits of candidate tobacco harm reduction (THR) products, such as ENDS, heated tobacco products, and modern oral tobacco products. RBRC conducts prospective observational cohort studies to characterize adults’ longitudinal tobacco product use transitions, including patterns of using the same products, switching products, adding products, initiating products, and stopping use of products. RBRC also designs and conducts consumer experience testing, flavor preference and impact studies, and studies of potential consumers’ risk perceptions, behavioral intentions, and understanding of the labels, labelling, and advertising of candidate THR products. Results of these studies help to inform PMTA, MRTPA, and other applicable regulatory assessments of the potential impact of candidate THR products on future tobacco use behavior and population health.
Sarah is a science engagement specialist focusing on harm reduction and science communication. She joined BAT in 2010 to establish R&D’s science engagement team to better communicate the science behind less-risky nicotine products to regulatory and general audiences. She drove a real change in BAT’s publishing strategy and created the visitor programme, science exhibition and a series of award-winning science reports – which showcased the company’s reduced risk product research in an accessible way. Prior to BAT, she held various publishing roles at Nature, Elsevier, Wiley and BioMedCentral. She holds a BSc in genetics and an MSc in plant genetics both from the University of Toronto, and her research has been published in Science. She is also dedicated to choral singing!
Vicki Crowder is the President of Custom Technologies which is headquartered in Las Vegas, Nevada. She is also the President and Co-Founder of Custom Teleconnect, Inc. which has provided software solutions and services to the adult correctional industry for more than 20 years. Upon the request of Sheriff’s and jail administrators in 2012, Custom Technologies with the help of law enforcement, designed a jail/prison specific eCigarette ~ eCig4Inmate to replace traditional tobacco products being sold in jail and prison commissaries, and to meet the very specific safety requirements needed for incarcerated adults suffering from nicotine withdrawal in a very stressful environment. eCig4nmate has significantly reduced the use of dangerous black-market contraband being smoked in “smoke-free” jails and prisons as well. Over the past 10 years, Vicki has become a fierce harm reduction advocate for this vulnerable adult population. Her dream would be to one day provide educational materials on harm minimization between tobacco products to the incarcerated population, with the hope they will not return to the more harmful options upon release. Vicki belongs to many State and National Law Enforcement and Vaping/Harm Reduction associations.
TBD
Biography coming soon.
Sarah is a science engagement specialist focusing on harm reduction and science communication. She joined BAT in 2010 to establish R&D’s science engagement team to better communicate the science behind less-risky nicotine products to regulatory and general audiences. She drove a real change in BAT’s publishing strategy and created the visitor programme, science exhibition and a series of award-winning science reports – which showcased the company’s reduced risk product research in an accessible way. Prior to BAT, she held various publishing roles at Nature, Elsevier, Wiley and BioMedCentral. She holds a BSc in genetics and an MSc in plant genetics both from the University of Toronto, and her research has been published in Science. She is also dedicated to choral singing!
Bio coming soon!
Azim Chowdhury advises domestic and international corporations on regulatory compliance with the U.S. Food and Drug Administration (FDA) and its global counterparts, particularly focusing on vapor, nicotine, tobacco product and cannabis/CBD regulation, as well as food-contact materials.
He counsels tobacco, e-cigarette, e-liquid and CBD manufacturers, distributors, retailers, suppliers, and trade associations on matters relating to regulatory compliance, as well as public policy initiatives. Azim is nationally recognized as an expert on the Family Smoking Prevention and Tobacco Control Act, which amended the Food, Drug and Cosmetic Act to give FDA authority over tobacco products, as well the Agency’s “Deeming Rule” which extended those authorities to previously unregulated products such as electronic nicotine delivery systems (ENDS), e-liquids, cigars, hookah/shisha, and heat-not-burn tobacco products. Azim also advises companies and trade associations on state and global law compliance, including in Canada, the United Kingdom, the EU, and China.
Dr. Autumn Bernal, PhD
PhD, Genetics, Genomics, Integrated Toxicology & Environmental Health – Duke University (USA) | BSc. Biology, Psychology – University of Oregon (USA)
Dr. Autumn Bernal is the Founder & Principle Scientist at ToxCreative, LLC. Dr. Bernal is a toxicologist with over 15 years of experience in toxicology study design, exposure assessment, and human health risk assessment. Her focal areas include safety assessments for product development and integration of non-clinical and clinical studies to evaluate potential human health risk.
